ResearcherUniversity of TsukubaActive in the last 2 years
Haruko Numajiri
Matched on ORCID iD 0000-0002-7181-4904; OpenAlex author ID A5085477743. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 2 papers
Papers 7
- Japanese Nationwide Prospective Data of Proton Therapy for Liver Metastasis From Pancreatic Cancer. Co-author DOI 10.1016/j.ijpt.2025.101291↗
- Clinical Characteristics and Treatment Courses of Exceptional Long-Term Survivors After Multimodal Therapy Including Proton Beam Therapy for Borderline Resecta… Co-author DOI 10.7759/cureus.115391↗
- Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. First author DOI 10.1186/s12957-025-03992-y↗
- Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan. Co-author DOI 10.1002/cam4.6611↗
- Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: a phase I/II… Co-author DOI 10.1186/s12885-023-11110-y↗
- Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable locally advanced (UR-LA) pancreatic duc… Co-author DOI 10.1016/j.suronc.2021.101542↗
- Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer. Co-author DOI 10.1016/j.radonc.2019.03.012↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hideyuki Sakurai · 6 shared papers, 2019–2026 · strength 0.96
- Paper Clinical Characteristics and Treatment Courses of Exceptional Long-Term Survivors After Multimodal Therapy Including Pr… DOI 10.7759/cureus.115391↗
- Paper Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. DOI 10.1186/s12957-025-03992-y↗
- Paper Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan. DOI 10.1002/cam4.6611↗
- Osamu Shimomura · 4 shared papers, 2021–2026 · strength 0.68
- Paper Clinical Characteristics and Treatment Courses of Exceptional Long-Term Survivors After Multimodal Therapy Including Pr… DOI 10.7759/cureus.115391↗
- Paper Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. DOI 10.1186/s12957-025-03992-y↗
- Paper Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally … DOI 10.1186/s12885-023-11110-y↗
- Yuichi Hiroshima · 4 shared papers, 2019–2025 · strength 0.58
- Paper Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. DOI 10.1186/s12957-025-03992-y↗
- Paper Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan. DOI 10.1002/cam4.6611↗
- Paper Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable… DOI 10.1016/j.suronc.2021.101542↗
- Tatsuya Oda · 3 shared papers, 2021–2025 · strength 0.43
- Paper Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. DOI 10.1186/s12957-025-03992-y↗
- Paper Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally … DOI 10.1186/s12885-023-11110-y↗
- Paper Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable… DOI 10.1016/j.suronc.2021.101542↗
- Yoshihiro Miyazaki · 3 shared papers, 2021–2025 · strength 0.43
- Paper Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. DOI 10.1186/s12957-025-03992-y↗
- Paper Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally … DOI 10.1186/s12885-023-11110-y↗
- Paper Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable… DOI 10.1016/j.suronc.2021.101542↗
- Nobuyoshi Fukumitsu · 2 shared papers, 2019–2026 · strength 0.37
- Masato Endo · 2 shared papers, 2023–2025 · strength 0.32
- Paper Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. DOI 10.1186/s12957-025-03992-y↗
- Paper Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally … DOI 10.1186/s12885-023-11110-y↗
- Kiichiro Tsuchiya · 2 shared papers, 2023–2025 · strength 0.32
- Paper Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. DOI 10.1186/s12957-025-03992-y↗
- Paper Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally … DOI 10.1186/s12885-023-11110-y↗
- Hisashi Yamaguchi · 1 shared paper, 2026 · strength 0.28
- Norio Katoh · 1 shared paper, 2026 · strength 0.28
- Hiromitsu Nakahashi · 1 shared paper, 2025 · strength 0.19
- Takahito Nakajima · 1 shared paper, 2023 · strength 0.13
- Yusuke Ohara · 1 shared paper, 2021 · strength 0.11
- Tsuyoshi Enomoto · 1 shared paper, 2021 · strength 0.11
- Yoshimasa Akashi · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.